Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

Stefan Kaufmann, former CEO of Tokyo-based Olympus, stepped down in October after the company investigated an allegation that the executive purchased illegal drugs.

Officials commissioned the independent review in September in response to a study that found tampons may expose users to metals.

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Dexcom received FDA clearance in March for the first over-the-counter glucose monitor, called Stelo. It’s cleared for adults who don’t take insulin, including people with Type 2 diabetes. The wellness ...

Medtronic and Johnson & Johnson are pursuing a market that leader Boston Scientific predicts could hit $6 billion by 2030.

Boston Scientific has updated the instructions for its Polarx and Polarx FIT cryoablation balloon catheters, the Food and Drug Administration said Wednesday. The update followed a higher than expected ...

The company collaborated with Zimmer Biomet on its Persona IQ device, which is slated for a full market release this year. Canary is also working on an implantable monitor for heart failure patients.

Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety complaints were listed that BD didn’t report within the required timeframe.

Embecta will cut approximately 125 jobs in Andover, Massachusetts, after announcing last week that it will discontinue its insulin patch pump program, a company spokesperson told MedTech Dive in an ...